Jason E. Chan

Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced Sarcoma

S. Singer, C. Kelly, W. Tap, 2021, Clinical cancer research : an official journal of the American Association for Cancer Research.

Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center

C. Antonescu, S. D'Angelo, S. Singer, 2022, Journal for ImmunoTherapy of Cancer.

Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets

Narasimhan P. Agaram, N. Socci, N. Schultz, 2021, Nature Communications.

Journal Pre-proof rThe Role of Chemotherapy Plus Immune Checkpoint Inhibitors in Oncogenic Driven Non-Small Cell Lung Cancer: A University California Lung Cancer Consortium Retrospective Study

Goldman, S. Schokrpur, K. Kelly, 2022 .

Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma

Narasimhan P. Agaram, Narasimhan P Agaram, L. Qin, 2022, Nature Communications.

A phase 2 study of epacadostat and pembrolizumab in patients with advanced sarcoma.

L. Qin, C. Antonescu, S. Singer, 2019, Clinical Cancer Research.

A phase 2 study of epacadostat and pembrolizumab in patients with advanced sarcoma.

L. Qin, C. Antonescu, S. Singer, 2023, Clinical Cancer Research.